Title Method for treating abnormal B-amyloid aggregation mediated diseases
Year 2018
Country TW、US
Inventor LEE-CHEN, GUEY-JEN
Co-inventor LIN, WENWEI
Cert. No. I633881、US10,716,768B2
Introduction The present invention provides a use of a compound to prepare a pharmaceutical composition for treating abnormal β-amyloid aggregation mediated diseases. The compound is represented by the following formula (I): Figure US10716768-20200721-C00001 wherein A, B, R1, R2, R3, R4, R5 and R6 are defined in the specification.
Validity 2037/07/21
Domain Medicine_and_Health
View count: 107